Gesco (GSC1) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
9 Jun, 2025Executive summary
Sales declined 8.4% year-over-year to €513.8 million, with net income after minority interests dropping 79% to €4.4 million and EPS at €0.42.
EBIT fell to €15.2 million from €35.9 million, impacted by a €9 million loss from the sale of loss-making divisions and one-off effects.
Portfolio was streamlined with the sale of AstroPlast and Doerrenberg's Foundry and Steelworks, focusing on more profitable core businesses.
Equity ratio improved to 62.3% despite a €9 million share buyback; net debt/EBITDA reduced to 0.7.
The group remains financially robust, with strong liquidity and access to credit lines.
Financial highlights
Revenue: €513.8 million (down from €560.7 million year-over-year).
EBIT: €15.2 million (vs. €35.9 million prior year); EBIT margin 3.0% (6.4%).
EBITDA: €36.7 million (vs. €59.0 million prior year).
Net income after minority interests: €4.4 million (vs. €20.9 million prior year).
EPS: €0.42 (vs. €1.93 prior year).
Equity: €270.1 million; equity ratio: 62.3%.
Net debt: €24.0 million; net debt/EBITDA: 0.7.
Dividend proposal: €0.10 per share (yield ~0.7%).
Outlook and guidance
2025 expected to see a significant recovery in net income and high single-digit sales growth, but not yet reaching 2021–2023 levels.
Adjusted 2024 sales (excluding divested units) at €480.1 million; 2025 sales to increase from this base.
Ongoing focus on organic and inorganic growth, with a well-filled M&A pipeline and plans for at least one basic and one add-on acquisition.
Macroeconomic environment remains challenging, with limited tailwind expected from the economy.
Latest events from Gesco
- Earnings rose sharply despite lower sales, but 2025 guidance was revised downward.GSC1
Q3 202512 Nov 2025 - Earnings and margins improved despite lower sales, with stable guidance for 2025.GSC1
H1 202513 Aug 2025 - Sales and earnings fell, but GESCO upholds robust guidance for 2024.GSC1
Q3 202413 Jun 2025 - Sales and earnings fell significantly in H1 2024, prompting a downward revision of full-year guidance.GSC1
H1 202413 Jun 2025 - Adjusted sales and earnings growth achieved despite challenging market conditions.GSC1
Q1 20256 Jun 2025